November 4, 2021
Axcelead said on November 1 that it has sealed a joint research accord with Kyowa Kirin and xFOREST Therapeutics, an upstart originating from Kyoto University, to discover multiple drugs that target RNA structures. Axcelead and Kyowa Kirin have been collaborating...read more